Semaglutide Tablet Franchise in Ahmedabad

Antidiabetic Tablet Supplier in Mumbai

Diabetes Medicine Distributor in Delhi

GLP 1 Tablet Manufacturer in Bangalore

Blood Sugar Control Tablet Stockist in Hyderabad
Semaglutide Tablet Exporter in Chandigarh

Home/Products /semaglutide-7mg-tablet

Sematime 7 Tablet

Composition : Semaglutide (7mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 1x10

Price : ₹350/-

Sematime 7 Tablet containing Semaglutide 7 mg is an advanced antidiabetic medicine used for effective management of type 2 diabetes. It helps in controlling blood sugar levels, improving insulin response, and supporting weight control, making it suitable for long-term diabetes care.

Semaglutide works by enhancing insulin secretion when blood sugar levels are high, reducing excess glucose production, and slowing digestion. This helps maintain stable glucose levels throughout the day and reduces hunger, supporting better metabolic control.

The formulation provides strong and sustained glycemic control along with added benefits of weight management, improving overall patient outcomes. It is widely prescribed in patients who require better sugar control with modern therapy options.

With the growing diabetic population and increasing demand for effective therapies, this product offers strong market potential in chronic care. Its high prescription demand, patient-friendly benefits, and consistent market movement make it a valuable addition for expanding business in the antidiabetic segment.

Read More

About the Product

Sematime 7 Tablet containing Semaglutide 7 mg is an advanced antidiabetic medicine used for effective management of type 2 diabetes. It helps in controlling blood sugar levels, improving insulin response, and supporting weight control, making it suitable for long-term diabetes care.

Semaglutide works by enhancing insulin secretion when blood sugar levels are high, reducing excess glucose production, and slowing digestion. This helps maintain stable glucose levels throughout the day and reduces hunger, supporting better metabolic control.

The formulation provides strong and sustained glycemic control along with added benefits of weight management, improving overall patient outcomes. It is widely prescribed in patients who require better sugar control with modern therapy options.

With the growing diabetic population and increasing demand for effective therapies, this product offers strong market potential in chronic care. Its high prescription demand, patient-friendly benefits, and consistent market movement make it a valuable addition for expanding business in the antidiabetic segment.

Some patients may experience nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort, or constipation. These effects are generally mild and tend to improve over time. Rarely, serious effects such as pancreatitis or allergic reactions may occur and require immediate medical attention.

Sematime 7 Tablet is indicated for the management of type 2 diabetes mellitus in adults who require better glycemic control along with diet and exercise. It helps lower blood sugar levels, supports weight reduction, and reduces the risk of long-term diabetes-related complications when used as part of a comprehensive treatment plan.

This medicine should be taken under medical supervision. It is not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Patients with a history of pancreatitis, thyroid disorders, or severe gastrointestinal disease should consult their healthcare provider before use. Regular monitoring of blood glucose levels is advised during treatment.

Store in a cool and dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation